All articles by

AbbVie agrees to acquire Gilgamesh’s bretisilocin for $1.2bn

AbbVie has signed a definitive agreement to acquire Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin, for up to $1.2bn, including an…
Genentech begins construction of North Carolina manufacturing site

Genentech, a member of the Roche Group, has commenced construction of a new manufacturing site in Holly Springs in the…